Eugene Myron Holuka's Net Worth
$1.28 Thousand
Who is Eugene Myron Holuka?
Eugene Myron Holuka does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Citius Pharmaceuticals, Inc., and CITIUS ONCOLOGY, INC..
SEC CIK
Eugene Myron Holuka's CIK is 0001678292
Past Insider Trading and Trends
2021 was Eugene Myron Holuka's most active year for acquiring shares with 3 total transactions. Eugene Myron Holuka's most active month to acquire stocks was the month of September. 2024 was Eugene Myron Holuka's most active year for disposing of shares, totalling 2 transactions. Eugene Myron Holuka's most active month to dispose stocks was the month of February. 2016 saw Eugene Myron Holuka paying a total of $160,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2024 Eugene Myron Holuka cashed out on 2,463 shares for a total of $36.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Citius Pharmaceuticals, Inc. (CTXR) Snapshot price: $0.54
InvestorEugene Myron Holuka owns 2,367 units of Common Stock which is worth $1,278.18. From 2016 to 2024 Eugene Myron Holuka acquired a total of 2,415 shares in Citius Pharmaceuticals, Inc. at a cost of $36.23, Eugene also disposed a total of 48 shares of Citius Pharmaceuticals, Inc. equalling to $36.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.37K |
$0.39 | $0.23 | 2.37K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CITIUS ONCOLOGY, INC. (TENK) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||